Literature DB >> 1504288

Functional assessment staging (FAST) in Alzheimer's disease: reliability, validity, and ordinality.

S G Sclan1, B Reisberg.   

Abstract

Evaluation of changes in functional performance and activities of daily living skills is an essential aspect of the assessment of elderly individuals with chronic illness. Although functional decrement is a central aspect of Alzheimer's disease (AD), many measures currently utilized to assess these changes have limitations. Empirical and systematic examination of the functional changes occurring in patients with AD has resulted in the development of an assessment measure termed Functional Assessment Staging (FAST) that allows for the specific evaluation of these changes throughout the entire course of AD. In this paper the results of three separate investigations regarding the reliability, validity, and progressive ordinality of FAST are described. The results indicate that FAST is a reliable and valid assessment technique for evaluating functional deterioration in AD patients throughout the entire course of the illness. Moreover, the results suggest that the FAST elucidates a characteristic pattern of progressive, ordinal, and functional decline in AD. Because the elements of functional capacity incorporated in FAST are relatively universal and readily ascertainable, as well as characteristic of the course of AD, FAST can serve as a strong diagnostic and differential diagnostic aid for clinicians. The sensitivity of FAST to the entire course of AD, even in its most severe stages, may be indicative of the potential value of this instrument for further investigation of the temporal longitudinal course of AD, and of the relationships between clinical pathology and neuropathology throughout the entire longitudinal course of AD.

Entities:  

Mesh:

Year:  1992        PMID: 1504288     DOI: 10.1017/s1041610292001157

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN: 1041-6102            Impact factor:   3.878


  113 in total

1.  Effect of a combined walking and conversation intervention on functional mobility of nursing home residents with Alzheimer disease.

Authors:  R M Tappen; K E Roach; E B Applegate; P Stowell
Journal:  Alzheimer Dis Assoc Disord       Date:  2000 Oct-Dec       Impact factor: 2.703

2.  Relating memory to functional performance in normal aging to dementia using hierarchical Bayesian cognitive processing models.

Authors:  William R Shankle; James P Pooley; Mark Steyvers; Junko Hara; Tushar Mangrola; Barry Reisberg; Michael D Lee
Journal:  Alzheimer Dis Assoc Disord       Date:  2013 Jan-Mar       Impact factor: 2.703

Review 3.  [Whats new on dementia?].

Authors:  S Riu-Subirana; J L Rodríguez-Cubas
Journal:  Aten Primaria       Date:  2006-01       Impact factor: 1.137

4.  The measurement of everyday cognition (ECog): scale development and psychometric properties.

Authors:  Sarah Tomaszewski Farias; Dan Mungas; Bruce R Reed; Deborah Cahn-Weiner; William Jagust; Kathleen Baynes; Charles Decarli
Journal:  Neuropsychology       Date:  2008-07       Impact factor: 3.295

5.  Nursing home care for people with dementia and residents' quality of life, quality of care and staff well-being: design of the Living Arrangements for people with Dementia (LAD)-study.

Authors:  Bernadette M Willemse; Dieneke Smit; Jacomine de Lange; Anne Margriet Pot
Journal:  BMC Geriatr       Date:  2011-03-17       Impact factor: 3.921

6.  Alzheimer's disease: rapid and slow progression.

Authors:  Craig J Thalhauser; Natalia L Komarova
Journal:  J R Soc Interface       Date:  2011-06-08       Impact factor: 4.118

7.  A study protocol for the development of a multivariable model predicting 6- and 12-month mortality for people with dementia living in residential aged care facilities (RACFs) in Australia.

Authors:  Ross Bicknell; Wen Kwang Lim; Andrea B Maier; Dina LoGiudice
Journal:  Diagn Progn Res       Date:  2020-10-07

8.  Do serum GDNF levels correlate with severity of Alzheimer's disease?

Authors:  Maryam Sharif; Maryam Noroozian; Farshad Hashemian
Journal:  Neurol Sci       Date:  2020-11-19       Impact factor: 3.307

9.  Critical appraisal of the long-term impact of memantine in treatment of moderate to severe Alzheimer's disease.

Authors:  Umamon Puangthong; Ging-Yuek Robin Hsiung
Journal:  Neuropsychiatr Dis Treat       Date:  2009-11-02       Impact factor: 2.570

10.  Video decision support tool for advance care planning in dementia: randomised controlled trial.

Authors:  Angelo E Volandes; Michael K Paasche-Orlow; Michael J Barry; Muriel R Gillick; Kenneth L Minaker; Yuchiao Chang; E Francis Cook; Elmer D Abbo; Areej El-Jawahri; Susan L Mitchell
Journal:  BMJ       Date:  2009-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.